Michael Liebowitz

Last updated
Michael R. Liebowitz
NationalityUSA
Alma mater Yale University (B.A, 1965)
Yale University School of Medicine (M.D., 1969) [1]
Occupationpsychiatrist, medical researcher, professor, author
Known forresearch work in anxiety disorders
Liebowitz social anxiety scale

Dr. Michael R. Liebowitz is a Columbia University psychiatrist and founder of the Anxiety Disorders Clinic, the first of its kind, at the New York State Psychiatric Institute. Liebowitz pioneered research on the molecular basis of love and wrote a book on the topic, "The Chemistry of Love." [2]

Contents

Early life and education

He was educated at Yale University, graduating with a B.A. (Cum Laude) in 1965, and with an M.D. degree from its medical school in 1969. [1]

Leibowitz did his medical internship and medical residency at Harlem Hospital in New York City from 1969 to 1971 and, from 1974 to 1977, his psychiatric residencies were completed at the Medical Center Hospital of Vermont and the New York State Psychiatric Institute. [1]

Career

In 1985, he researched and highlighted an under-recognized status of social anxiety disorder (SAD). This led to subsequent cognitive research and treatments for anxiety disorders. He created the Liebowitz social anxiety scale, now a widely used primary outcome measure in clinical research on SAD.

In 1997 he established the Medical Research Network in New York City which performs studies on medicines. [3]

In 2007, Liebowitz retired as Director of the Anxiety Disorders Clinic at the New York State Psychiatric Institute, a position which he had held since 1982. [3]

Since 1977, he has been an instructor and professor of Medicine (Clinical Psychiatry) at Columbia University College of Physicians and Surgeons. [1]

Related Research Articles

Aaron T. Beck American psychiatrist

Aaron Temkin Beck is an American psychiatrist who is professor emeritus in the department of psychiatry at the University of Pennsylvania. He is regarded as the father of both cognitive therapy and cognitive behavioral therapy. His pioneering theories are widely used in the treatment of clinical depression and various anxiety disorders. Beck also developed self-report measures of depression and anxiety, notably the Beck Depression Inventory (BDI) which became one of the most widely used instruments for measuring depression severity. In 1994, he and his daughter, psychologist Judith S. Beck, founded the nonprofit Beck Institute for Cognitive Behavior Therapy with the goal of providing excellence in CBT treatment, training, and research. Beck currently serves as President Emeritus of the organization.

John C. Markowitz is an American physician, a Professor of Clinical Psychiatry at the Columbia University College of Physicians & Surgeons and a Psychiatric Researcher at the New York State Psychiatric Institute. For several decades he has conducted research on psychotherapies and medications as treatments for mood disorders, anxiety disorders, and personality disorders. He is currently conducting an outcome study of three psychotherapies for posttraumatic stress disorder (PTSD) thanks to a five-year grant from the National Institute of Mental Health. He is most widely published in the area of interpersonal psychotherapy or IPT, a manualized form of treatment, in which he was trained by the late Gerald L. Klerman, M.D. Dr. Markowitz is a graduate of Columbia University and Columbia University College of Physicians and Surgeons and received his psychiatric residency training at the Payne Whitney Psychiatric Clinic of Cornell University Medical School/New York-Presbyterian Hospital.

Lisa Dixon is a Professor of Psychiatry at the University of Maryland, Baltimore, where her primary research interests have focused on persons with severe mental illnesses who have co-morbid medical and substance use disorders, homelessness, and other vulnerabilities as well as on services to family members. She is the director of the Division of Services Research within the Department of Psychiatry at Maryland, and joined the Veterans Affairs Capital Health Care Network as Associate Director for Research at the Mental Illness Research, Education, and Clinical Center. She was previously the Director of Education and Residency Training at Maryland.

The Liebowitz Social Anxiety Scale (LSAS) is a short questionnaire developed in 1987 by Michael Liebowitz, a psychiatrist and researcher at Columbia University and the New York State Psychiatric Institute. Its purpose is to assess the range of social interaction and performance situations feared by a patient in order to assist in the diagnosis of social anxiety disorder. It is commonly used to study outcomes in clinical trials and, more recently, to evaluate the effectiveness of cognitive-behavioral treatments. The scale features 24 items, which are divided into two subscales. 13 questions relate to performance anxiety and 11 concern social situations. The LSAS was originally conceptualized as a clinician-administered rating scale, but has since been validated as a self-report scale.

The Institute of Living is a comprehensive psychiatric facility in Hartford, Connecticut, that offers care across the spectrum of psychiatric services, including:

Lawrence Kolb

Lawrence Coleman Kolb was an American psychiatrist who was the New York State Commissioner of Mental Hygiene from 1975 to 1978.

New York Eye and Ear Infirmary Hospital in New York, United States

New York Eye and Ear Infirmary of Mount Sinai (NYEE) is located at East 14th Street and Second Avenue in lower Manhattan, New York City. Founded on August 14, 1820, NYEE is America's first specialty hospital and one of the most prominent in the fields of ophthalmology and otolaryngology in the world, providing primary inpatient and outpatient care in those specialties. Previously affiliated with New York Medical College, as of 2013 it is affiliated with the Icahn School of Medicine at Mount Sinai as a part of the membership in the Mount Sinai Health System.

Child and adolescent psychiatry is a branch of psychiatry that focuses on the diagnosis, treatment, and prevention of mental disorders in children, adolescents, and their families. It investigates the biopsychosocial factors that influence the development and course of these psychiatric disorders and treatment responses to various interventions.

Social anxiety is nervousness in social situations. Some disorders associated with the social anxiety spectrum include anxiety disorders, mood disorders, autistic spectrum disorders, eating disorders, and substance use disorders. Individuals higher in social anxiety avert their gazes, show fewer facial expressions, and show difficulty with initiating and maintaining a conversation. Trait social anxiety, the stable tendency to experience this nervousness, can be distinguished from state anxiety, the momentary response to a particular social stimulus. Nearly 90% of individuals, more of whom are women, report feeling symptoms of social anxiety at some point in their lives. Half of the individuals with any social fears meet the criteria for social anxiety disorder. Age, culture, and gender impact the severity of this disorder. The function of social anxiety is to increase arousal and attention to social interactions, inhibit unwanted social behavior, and motivate preparation for future social situations.

Nathan Schellenberg Kline, M.D. was an American scientist, researcher in the field of psychology and psychiatrist best known for his work with psychopharmacologic drugs. Having been influential in the development of the very first antipsychotic and antidepressant medications in the 1950s, Kline is often regarded as the "father of psychopharmacology."

Social anxiety disorder (SAD), also known as social phobia, is an anxiety disorder characterized by sentiments of fear and anxiety in social situations, causing considerable distress and impaired ability to function in at least some aspects of daily life. These fears can be triggered by perceived or actual scrutiny from others. Individuals with social anxiety disorder fear negative evaluation from other people.

Harold Alan Pincus, M.D. is the Vice Chair of the Department of Psychiatry at Columbia University’s College of Physicians and Surgeons.

Michael B. First is an American psychiatrist who focuses on diagnostic criteria for mental disorders. He is Professor of Clinical Psychiatry at Columbia University. First was one of the editors of DSM-IV-TR, the Editor of Text and Criteria for the DSM-IV, and the editor of the Structured Clinical Interview for DSM-IV. He also served as consultant to the World Health Organization for the revision of ICD-11.

Michael Terman is an American psychologist best known for his work in applying the biological principles of the circadian timing system to psychiatric treatments for depression and sleep disorders. This subspecialty is known as Chronotherapeutics.

The Rare Diseases Clinical Research Network (RDCRN) is an initiative of the Office of Rare Diseases Research (ORDR). RDCRN is funded by the ORDR, the National Center for Advancing Translational Sciences and collaborating institute centers. The RDCRN is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.

Fredric Neal Busch is a Weill Cornell Medical College professor of clinical psychiatry based in New York City. He is also a faculty member at the Columbia University Center for Psychoanalytic Training and Research.

Igor Galynker American psychiatrist

Igor Galynker is a Russian-born American psychiatrist, clinician and researcher. His diverse interests include behavioral addictions, bipolar disorder, suicide prevention, and the role of family in psychiatric illness. He has published on these topics both in professional journals and in the lay press. Most recently his research has been devoted to describing a suicide-specific clinical state, a phenotype of the Suicide Crisis Syndrome (SCS).

Ronald Robert Fieve was an American psychiatrist known for his work on the use of lithium in treatment of mood disorders. He has authored four popular science books, "Moodswing", "Bipolar II", "Prozac" and "Bipolar Breakthrough".

Andrew J. Gerber

Andrew J. Gerber is an American psychoanalyst and the current president and medical director of Silver Hill Hospital in New Canaan, Connecticut. His principal interests and research lie in studying the neurobiological bases of social cognition, particularly in relation to autism spectrum disorders and change in response to psychotherapy. He is a member of the American Academy of Child and Adolescent Psychiatry, American Psychiatric Association, American Psychoanalytic Association and the Psychoanalytic Psychodynamic Research Society.

Augustus John Rush is an internationally renowned psychiatrist. He is a Professor Emeritus in Duke-NUS Medical School at the National University of Singapore (NUS), and Adjunct Professor of Psychiatry and Behavioral Sciences at Duke University School of Medicine. He has authored and edited more than 10 books, and over 600 scientific journal articles that are largely focused on the diagnosis and treatment of depressive and bipolar disorders.

References

  1. 1 2 3 4 "CV of Dr. Michael R. Liebowitz", Medical Research Network, New York, NY
  2. Woods, Michael (Feb 8, 1995). "THE CHEMISTRY OF LOVE". Deseret News . Retrieved 12 November 2020.
  3. 1 2 Medical Research Network", Medical Research Network, New York, NY
  4. Liebowitz, Michael, R. (1983). The Chemistry of Love. Boston: Little, Brown, & Co.
  5. Collins, Glenn, "CHEMICAL CONNECTIONS: PATHWAYS OF LOVE", New York Times, February 14, 1983